Sara Centonze
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
Papers in
-
- Histone Deacetylase Inhibitors Research 1
- Oncology 4
- PARP inhibition in cancer therapy 3
- Co-authors
- Anna Diana (5 shared papers)E. Franzese (5 shared papers)Michele Orditura (5 shared papers)Ferdinando De Vita (4 shared papers)Francesca Carlino (3 shared papers)Sandro Pignata (4 shared papers)Fortunato Ciardiello (4 shared papers)Luigi Pio Guerrera (2 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Biomedicines (2 papers)Current Oncology Reports (1 paper)Frontiers in Psychiatry (1 paper)Cells (1 paper)
- Partner nations
- ItalyGermanyUnited States
In The Last Decade
Sara Centonze
10 papers receiving 280 citations
Peers
Comparison fields: 5 of 66
- Reproductive Medicine 58
- Oncology 154
- Toxicology 9
- Cancer Research 38
- Molecular Biology 152
Countries citing papers authored by Sara Centonze
This map shows the geographic impact of Sara Centonze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Centonze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Centonze more than expected).
Fields of papers citing papers by Sara Centonze
This network shows the impact of papers produced by Sara Centonze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Centonze. The network helps show where Sara Centonze may publish in the future.
Co-authors
The 25 scholars most cited alongside Sara Centonze, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 155 | |
| 2 | 2018 | 69 | |
| 3 | 2024 | 14 | |
| 4 | 2019 | 11 | |
| 5 | 2020 | 11 | |
| 6 | 2021 | 9 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 3 | |
| 11 | 2020 | 0 |
About Sara Centonze
Sara Centonze is a scholar working on Molecular Biology, Oncology, Cell Biology, Reproductive Medicine and Immunology, having authored 11 papers that have together received 286 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Breast Cancer Treatment Studies (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Mental Health Research Topics (1 paper), Gestational Trophoblastic Disease Studies (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Reproductive Medicine (58 citations), Oncology (154 citations), Toxicology (9 citations), Cancer Research (38 citations) and Molecular Biology (152 citations). Sara Centonze has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include Anna Diana, E. Franzese, Michele Orditura, Ferdinando De Vita, Francesca Carlino, Sandro Pignata, Fortunato Ciardiello, Luigi Pio Guerrera, Marilena Di Napoli and Roberto Alfano. Their work appears in journals such as Frontiers in Oncology, Biomedicines, Current Oncology Reports, Frontiers in Psychiatry and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.